companies developing glp 1 drugs Solving the Unmet Needs in Obesity Treatment | Obesity Pulse The current range of weight-loss
Description
24 May 2026
Evidence-based lifestyle interventionsincluding structured dietary advice, physical activity programmes, and psychological supportshould be explored as first-line approaches
GLP-1 drugs alone produced $1.1 billion dollars in claims in 2024, more than a 29% increase from 2023
With this approval, and by launching a generic for Saxenda, we will provide patients in the US the first ever generic GLP-1 product specifically indicated for weight loss, said Ernie Richardsen, senior vice president, Head of US Commercial Generics at Teva
How quickly does semaglutide GLP-1 work
